Janssen Pharmaceutica Clinical Trials
Sponsors / Janssen Pharmaceutica
The ClinicalTrials.gov registry records 22 trials led by Janssen Pharmaceutica. Across the portfolio, 4 are in recruitment, 2 are active non-recruiting, and 13 have reached completion. 2 trials have been terminated or withdrawn. Across the portfolio, planned enrollment totals 5,876 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
22
Total Trials
4
Recruiting
2
Other Active
13
Completed
2
Terminated / Withdrawn
5,876
Total Enrollment
Termination reasons: Other100%
Recent Terminations
- Alzheimer Disease"Delayed due to COVID19. Study drug expired before could be used."
- Pain"the study was stopped due to non-availability of 4mg"
Active Trials (2 total)
- NCT04592237
- Prostate Cancer PHASE3NCT04181203
- NCT06477783
- Multiple Myeloma PHASE2NCT06353022
- Multiple Myeloma PHASE2NCT06505369
- Multiple Myeloma PHASE2NCT06189833